Anand Nikhilesh

Anand Nikhilesh


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2022 in Cells
Verified
Journal Article
Open access
PDF file
ANAnand Nikhilesh
Anand Nikhilesh
VGVasavi Rakesh Gorantla
Vasavi Rakesh Gorantla
SCSaravana Babu Chidambaram
Saravana Babu Chidambaram
Mounting evidence shows that the complex gut microbial ecosystem in the human gastrointestinal (GI) tract regulates the physiology of the central nervous system (CNS) via microbiota and the gut–brain (MGB) axis. The GI microbial ecosystem communicates with the brain through the neuroendocrine, immune, and autonomic nervous systems. Recent studies have bolstered the involvement of dysfunctional MGB axis signaling in the pathophysiology of several neurodegenerative, neurodevelopmental, and neuropsychiatric disorders (NPDs). Several investigations on the dynamic microbial system and genetic–environmental interactions with the gut microbiota (GM) have shown that changes in the composition, diversity and/or functions of gut microbes (termed “gut dysbiosis” (GD)) affect neuropsychiatric health by inducing alterations in the signaling pathways of the MGB axis. Interestingly, both preclinical and clinical evidence shows a positive correlation between GD and the pathogenesis and progression of NPDs. Long-term GD leads to overstimulation of hypothalamic–pituitary–adrenal (HPA) axis and the neuroimmune system, along with altered neurotransmitter levels, resulting in dysfunctional signal transduction, inflammation, increased oxidative stress (OS), mitochondrial dysfunction, and neuronal death. Further studies on the MGB axis have highlighted the significance of GM in the development of brain regions specific to stress-related behaviors, including depression and anxiety, and the immune system in the early life. GD-mediated deregulation of the MGB axis imbalances host homeostasis significantly by disrupting the integrity of the intestinal and blood–brain barrier (BBB), mucus secretion, and gut immune and brain immune functions. This review collates evidence on the potential interaction between GD and NPDs from preclinical and clinical data. Additionally, we summarize the use of non-therapeutic modulators such as pro-, pre-, syn- and post-biotics, and specific diets or fecal microbiota transplantation (FMT), which are promising targets for the management of NPDs.

23 January 2024 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
SCSaravana Babu Chidambaram
Saravana Babu Chidambaram
ANAnand Nikhilesh
Anand Nikhilesh
SVSudhir Rama Varma
Sudhir Rama Varma
SRSrinivasan Ramamurthy
Srinivasan Ramamurthy
CVChandrasekaran Vichitra
Chandrasekaran Vichitra
MEMusthafa Mohamed Essa
Musthafa Mohamed Essa
Superoxide dismutase (SOD) is a common antioxidant enzyme found majorly in living cells. The main physiological role of SOD is detoxification and maintain the redox balance, acts as a first line of defence against Reactive nitrogen species (RNS), Reactive oxygen species (ROS), and other such potentially hazardous molecules. SOD catalyses the conversion of superoxide anion free radicals (O 2 -.) into molecular oxygen (O 2) and hydrogen peroxide (H 2O 2) in the cells. Superoxide dismutases (SODs) are expressed in neurons and glial cells throughout the CNS both intracellularly and extracellularly. Endogenous oxidative stress (OS) linked with enlarged production of reactive oxygen metabolites (ROMs), inflammation, deregulation of redox balance, mitochondrial dysfunction and bioenergetic crisis are found to be prerequisite for neuronal loss in neurological diseases. Clinical and genetic studies indicate a direct correlation between mutations in SOD gene and neurodegenerative diseases, like Amyotrophic Lateral Sclerosis (ALS), Huntington’s disease (HD), Parkinson’s Disease (PD) and Alzheimer’s Disease (AD). Therefore, inhibitors of OS are considered as an optimistic approach to prevent neuronal loss. SOD mimetics like Metalloporphyrin Mn (II)-cyclic polyamines, Nitroxides and Mn (III)- Salen complexes are designed and used as therapeutic extensively in the treatment of neurological disorders. SODs and SOD mimetics are promising future therapeutics in the field of various diseases with OS-mediated pathology.

31 July 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
VCVichitra Chandrasekaran
Vichitra Chandrasekaran
THTousif Ahmed Hediyal
Tousif Ahmed Hediyal
ANAnand Nikhilesh
Anand Nikhilesh
PKPavan Heggadadevanakote Kendaganna
Pavan Heggadadevanakote Kendaganna
VGVasavi Rakesh Gorantla
Vasavi Rakesh Gorantla
SCSaravana Babu Chidambaram
Saravana Babu Chidambaram
Polyphenols are secondary metabolites from plant origin and are shown to possess a wide range of therapeutic benefits. They are also reported as regulators of autophagy, inflammation and neurodegeneration. The autophagy pathway is vital in degrading outdated organelles, proteins and other cellular wastes. The dysregulation of autophagy causes proteinopathies, mitochondrial dysfunction and neuroinflammation thereby contributing to neurodegeneration. Evidence reveals that polyphenols improve autophagy by clearing misfolded proteins in the neurons, suppress neuroinflammation and oxidative stress and also protect from neurodegeneration. This review is an attempt to summarize the mechanism of action of polyphenols in modulating autophagy and their involvement in pathways such as mTOR, AMPK, SIRT-1 and ERK. It is evident that polyphenols cause an increase in the levels of autophagic proteins such as beclin-1, microtubule-associated protein light chain (LC3 I and II), sirtuin 1 (SIRT1), etc. Although it is apparent that polyphenols regulate autophagy, the exact interaction of polyphenols with autophagy markers is not known. These data require further research and will be beneficial in supporting polyphenol supplementation as a potential alternative treatment for regulating autophagy in neurodegenerative diseases.

20 May 2025 in JMIR Medical Education
Verified
Journal Article
Open access
JCJoseph Cross
Joseph Cross
TKTarron Kayalackakom
Tarron Kayalackakom
RRRaymond E Robinson
Raymond E Robinson
AVAndrea Vaughans
Andrea Vaughans
RSRoopa Sebastian
Roopa Sebastian
JGJulia Elizabeth George
Julia Elizabeth George
Background: Standardized patients (SPs) have been crucial in medical education, offering realistic patient interactions to students. Despite their benefits, SP training is resource-intensive and access can be limited. Advances in artificial intelligence (AI), particularly with large language models such as ChatGPT, present new opportunities for virtual SPs, potentially addressing these limitations. Objectives: This study aims to assess medical students’ perceptions and experiences of using ChatGPT as an SP and to evaluate ChatGPT’s effectiveness in performing as a virtual SP in a medical school setting. Methods: This qualitative study, approved by the American University of Antigua Institutional Review Board, involved 9 students (5 females and 4 males, aged 22‐48 years) from the American University of Antigua College of Medicine. Students were observed during a live role-play, interacting with ChatGPT as an SP using a predetermined prompt. A structured 15-question survey was administered before and after the interaction. Thematic analysis was conducted on the transcribed and coded responses, with inductive category formation. Results: Thematic analysis identified key themes preinteraction including technology limitations (eg, prompt engineering difficulties), learning efficacy (eg, potential for personalized learning and reduced interview stress), verisimilitude (eg, absence of visual cues), and trust (eg, concerns about AI accuracy). Postinteraction, students noted improvements in prompt engineering, some alignment issues (eg, limited responses on sensitive topics), maintained learning efficacy (eg, convenience and repetition), and continued verisimilitude challenges (eg, lack of empathy and nonverbal cues). No significant trust issues were reported postinteraction. Despite some limitations, students found ChatGPT as a valuable supplement to traditional SPs, enhancing practice flexibility and diagnostic skills. Conclusions: ChatGPT can effectively augment traditional SPs in medical education, offering accessible, flexible practice opportunities. However, it cannot fully replace human SPs due to limitations in verisimilitude and prompt engineering challenges. Integrating prompt engineering into medical curricula and continuous advancements in AI are recommended to enhance the use of virtual SPs.

13 September 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
ANAnand Nikhilesh
Anand Nikhilesh
VGVasavi Rakesh Gorantla
Vasavi Rakesh Gorantla
RRRajeev Ranjan
Rajeev Ranjan
HMHani Morcos
Hani Morcos
Emotional intelligence (EI) is defined as ability of an individual to perceive, understand, regulate, control and utilise emotions. EI is a relatively nascent concept from the 1900s that attempts to connect emotion to general intelligence. Several clinical studies and survey research have confirmed positive association between EI and optimal mental and physical health, overall well-being, and on-aggressive behaviours. In this review, a brief overview on evolutional theory of EI, various models associated with EI, methods of classifying measures, and comparing various EI measurement methods are described. Indeed, EI assessment measures such as Multifactor EI Scale, Mayer-Salovey-Caruso Tests, Self-report Test, Trait EI Questionnaire, Bar-On Emotional Quotient Inventory, The Situational Test of Emotional Management, The Situational Test of Emotional Understanding, Emotional and Social competence Inventory are also discussed. The key purpose of this review is to encapsulate important components of EI to audiences, reap the benefits of evaluating EI and implying attributes to improve their emotional health and general well-being.

27 February 2023
Verified
Book Chapter
Open access
PDF file
AAAyoola Awosika
Ayoola Awosika
AOAdekunle E. Omole
Adekunle E. Omole
UAUzochukwu Adabanya
Uzochukwu Adabanya
ANAnand Nikhilesh
Anand Nikhilesh
RMRichard M Millis
Richard M Millis
Statins remain the most efficient hypolipidemic agent and their use is pivotal in primary, secondary, and tertiary treatment of cardiovascular disease, reducing both morbidity and mortality. Statins target 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes conversion of HMG-CoA to mevalonate, the committed and rate limiting step in hepatic production of cholesterol. Genetic predilections for hypercholesterolemia are known to be responsible for substantial morbidity and mortality from cardiovascular disease. Environmental or lifestyle factors such as dietary fat and carbohydrate may also contribute to cardiovascular disease mortality by both genetic and epigenetic mechanisms. Besides lipid-lowering, statins have pleiotropic effects which may contribute to their protection against cardiovascular and several other diseases wherein hypercholesterolemia is a risk factor. Evidence is emerging that the clinical outcomes of many diseases are improved when modifications of environmental or lifestyle factors play integral roles in treatment and preventive prescriptions. This chapter is, therefore, intended to inform physicians and other health care professionals about the environment-gene interactions underlying the main and pleiotropic effects of statins which may be employed to improve the efficacy of statin therapies.